Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP789297.RAyz8hJyYLWyIh-7oxgx9fRr4gQ5U--UKAiI2lVn6iPRk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP789297.RAyz8hJyYLWyIh-7oxgx9fRr4gQ5U--UKAiI2lVn6iPRk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP789297.RAyz8hJyYLWyIh-7oxgx9fRr4gQ5U--UKAiI2lVn6iPRk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP789297.RAyz8hJyYLWyIh-7oxgx9fRr4gQ5U--UKAiI2lVn6iPRk130_provenance.
- NP789297.RAyz8hJyYLWyIh-7oxgx9fRr4gQ5U--UKAiI2lVn6iPRk130_assertion description "[TOP2A has aroused particular interest as over-expression of its protein has been shown to correlate, both with amplification of HER2/neu, and with response to anthracycline-based chemotherapeutic agents in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP789297.RAyz8hJyYLWyIh-7oxgx9fRr4gQ5U--UKAiI2lVn6iPRk130_provenance.
- NP789297.RAyz8hJyYLWyIh-7oxgx9fRr4gQ5U--UKAiI2lVn6iPRk130_assertion evidence source_evidence_literature NP789297.RAyz8hJyYLWyIh-7oxgx9fRr4gQ5U--UKAiI2lVn6iPRk130_provenance.
- NP789297.RAyz8hJyYLWyIh-7oxgx9fRr4gQ5U--UKAiI2lVn6iPRk130_assertion SIO_000772 20100636 NP789297.RAyz8hJyYLWyIh-7oxgx9fRr4gQ5U--UKAiI2lVn6iPRk130_provenance.
- NP789297.RAyz8hJyYLWyIh-7oxgx9fRr4gQ5U--UKAiI2lVn6iPRk130_assertion wasDerivedFrom befree-2016 NP789297.RAyz8hJyYLWyIh-7oxgx9fRr4gQ5U--UKAiI2lVn6iPRk130_provenance.
- NP789297.RAyz8hJyYLWyIh-7oxgx9fRr4gQ5U--UKAiI2lVn6iPRk130_assertion wasGeneratedBy ECO_0000203 NP789297.RAyz8hJyYLWyIh-7oxgx9fRr4gQ5U--UKAiI2lVn6iPRk130_provenance.
- befree-2016 importedOn "2016-02-19" NP789297.RAyz8hJyYLWyIh-7oxgx9fRr4gQ5U--UKAiI2lVn6iPRk130_provenance.